Exhibitors 2018


Metodo diagnostico per il controllo della immunoterapia

Metodo diagnostico per il controllo della immunoterapia

This project proposes a novel immuno-enzymatic assay for serum PD-L1 protein determination, which is a novel innovative biomarker of response for immune checkpoint inhibitors cancer immunotherapy. We have identified small peptide ligands of PD-L1, which were able to bind PD-L1 protein. Taking advantage of these peptide ligands of PD-L1, we developed an immuno-enzymatic assay for serum PD-L1 determination. When clinically validated, this assay will offer a significant advantage to overcome some limitations of the currently available PD-L1 immunoassays.
Italy


Metodo diagnostico per il controllo della immunoterapia

Dott.ssa Selena Mimmi, Dott.ssa Francesca Trimboli, Prof. Camillo Palmieri

Selena Mimmihas a post-doc position (AIRC / FIRC fellowship) at the University Magna Grecia of Catanzaro, Italy. She got her Bachelor in Biothecnology and Master Degree in Medical Pharmaceutical and Veterinary Biotechnology, as well the PhD in Medical Biotechnology at the University Magna Graecia of Catanzaro. During her PhD she was focused on construction and analysis of combinatorial peptide library expressed on phages. Her list of publications includes more than 10 peer-reviewed papers published in international journals.
Francesca Trimbolihas a post-doc position at the University Magna Grecia of Catanzaro, Italy. She studied Biological Sciences in Naples, Italy, and received her PhD in molecular oncology and specialization in Clinical Biochemistry from the University Magna Grecia of Catanzaro, Italy. Her research focuses clinical biochemistry in veterinary field. Her list of publications includes more than 12 peer-reviewed papers published in international journals.
Camillo Palmieri is Associate Professor of Clinical Biochemistry at the University Magna Grecia of Catanzaro, Italy. He studied Biological Sciences in Pisa, Italy and received his PhD in molecular oncology from the University Magna Grecia of Catanzaro, Italy. His research focuses on the mechanisms underlying the pathogenesis of B-cell neoplastic diseases, as well the development of novel therapeutic and diagnostic approaches for B-cell neoplastic diseases based on idiotypic peptides. The list of publications includes more than 40 peer-reviewed papers published in international journals.


  C1 (pav. 5) - University Magna Graecia of Catanzaro
 2018

Back
 
Data updated on 2020-12-13 - 11.41.04 pm